High-dose intensity-modulated radiotherapy for prostate cancer using daily fiducial marker-based position verification: Acute and late toxicity in 331 patients

Radiation Oncology

Volumn 3, Issue 1, 2008, Pages

  Lips, Irene M ^a   Dehnad, Homan ^a   van Gils, Carla H ^a   Boeken Kruger, Arto E ^a   van der Heide, Uulke A ^a   van Vulpen, Marco ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BRACHYTHERAPY; COMPUTER ASSISTED RADIOTHERAPY; GASTROINTESTINAL TRACT; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MALE; MIDDLE AGED; PROSTATE TUMOR; RADIATION DOSE; RADIATION EXPOSURE; RADIATION INJURY; UROGENITAL SYSTEM;

AGED; AGED, 80 AND OVER; BRACHYTHERAPY; GASTROINTESTINAL TRACT; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; UROGENITAL SYSTEM;

EID: 45849084226     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-3-15     Document Type: Article

References (27)

1. Peeters ST Heemsbergen WD Koper PC van Putten WL Slot A Dielwart MF Bonfrer JM Incrocci L Lebesque JV Dose-response in radiotherapy for localized prostate cancer: Results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy J Clin Oncol 2006, 24:1990-1996. 10.1200/JCO.2005.05.2530 16648499
2. Pollack A Zagars GK Starkschall G Antolak JA Lee JJ Huang E von Eschenbach AC Kuban DA Rosen I Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial Int J Radiat Oncol Biol Phys 2002, 53:1097-1105. 10.1016/S0360-3016(02)02829-8 12128107
3. Zietman AL DeSilvio ML Slater JD Rossi CJ Jr. Miller DW Adams JA Shipley WU Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: A randomized controlled trial JAMA 2005, 294:1233-1239. 10.1001/ jama.294.10.1233 16160131
4. Eade TN Hanlon AL Horwitz EM Buyyounouski MK Hanks GE Pollack A What dose of external-beam radiation is high enough for prostate cancer? Int J Radiat Oncol Biol Phys 2007, 68:682-689. 17398026
5. Chen ME Johnston DA Tang K Babaian RJ Troncoso P Detailed mapping of prostate carcinoma foci: Biopsy strategy implications Cancer 2000, 89:1800-1809. 10.1002/ 1097-0142(20001015)89:8<1800::AID-CNCR21>3.0.CO;2-D 11042576
6. Cahlon O Hunt M Zelefsky MJ Intensity-modulated radiation therapy: supportive data for prostate cancer Semin Radiat Oncol 2008, 18:48-57. 10.1016/j.semradonc.2007.09.007 18082588
7. De Meerleer G Vakaet L Meersschout S Villeirs G Verbaeys A Oosterlinck W De Neve W Intensity-modulated radiotherapy as primary treatment for prostate cancer: Acute toxicity in 114 patients Int J Radiat Oncol Biol Phys 2004 60 777 787 15465194
8. Zelefsky MJ Fuks Z Hunt M Yamada Y Marion C Ling CC Amols H Venkatraman ES Leibel SA High-dose intensity modulated radiation therapy for prostate cancer: Early toxicity and biochemical outcome in 772 patients Int J Radiat Oncol Biol Phys 2002, 53:1111-1116. 10.1016/ S0360-3016(02)02857-2 12128109
9. Skala M Rosewall T Dawson L Divanbeigi L Lockwood G Thomas C Crook J Chung P Warde P Catton C Patient-assessed late toxicity rates and principal component analysis after image-guided radiation therapy for prostate cancer Int J Radiat Oncol Biol Phys 2007, 68:690-698. 17379434
10. De Meerleer GO Fonteyne VH Vakaet L Villeirs GM Denoyette L Verbaeys A Lummen N De Neve WJ Intensity-modulated radiation therapy for prostate cancer: Late morbidity and results on biochemical control Radiother Oncol 2007, 82:160-166. 10.1016/j.radonc.2006.12.007 17222931
11. Zelefsky MJ Chan H Hunt M Yamada Y Shippy AM Amols H Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer J Urol 2006, 176:1415-1419. 10.1016/ j.juro.2006.06.002 16952647
12. de Crevoisier R Tucker SL Dong L Mohan R Cheung R Cox JD Kuban DA Increased risk of biochemical and local failure in patients with distended rectum on the planning CT for prostate cancer radiotherapy Int J Radiat Oncol Biol Phys 2005, 62:965-973. 15989996
13. Dehnad H Nederveen AJ van der Heide UA van Moorselaar RJ Hofman P Lagendijk JJ Clinical feasibility study for the use of implanted gold seeds in the prostate as reliable positioning markers during megavoltage irradiation Radiother Oncol 2003, 67:295-302. 10.1016/ S0167-8140(03)00078-1 12865177
14. van der Heide UA Kotte AN Dehnad H Hofman P Lagenijk JJ van Vulpen M Analysis of fiducial marker-based position verification in the external beam radiotherapy of patients with prostate cancer Radiother Oncol 2007, 82:38-45. 10.1016/j.radonc.2006.11.002 17141903
15. Beckendorf V Guerif S Le Prise E Cosset JM Lefloch O Chauvet B Salem N Chapet O Bourdin S Bachaud JM Maingon P Lagrange JL Malissard L Simon JM Pommier P Hay MH Dubray B Luporsi E Bey P The GETUG 70 Gy vs. 80 Gy randomized trial for localized prostate cancer: Feasibility and acute toxicity Int J Radiat Oncol Biol Phys 2004, 60:1056-1065. 15519775
16. Michalski JM Winter K Purdy JA Parliament M Wong H Perez CA Roach M Bosch W Cox JD Toxicity after three-dimensional radiotherapy for prostate cancer on RTOG 9406 dose Level V Int J Radiat Oncol Biol Phys 2005, 62:706-713. 15936549
17. Peeters ST Heemsbergen WD van Putten WL Slot A Tabak H Mens JW Lebesque JV Koper PC Acute and late complications after radiotherapy for prostate cancer: Results of a multicenter randomized trial comparing 68 Gy to 78 Gy Int J Radiat Oncol Biol Phys 2005, 61:1019-1034. 15752881
18. Storey MR Pollack A Zagars G Smith L Antolak J Rosen I Complications from radiotherapy dose escalation in prostate cancer: Preliminary results of a randomized trial Int J Radiat Oncol Biol Phys 2000, 48:635-642. 11020558
19. Kotte AN Hofman P Lagendijk JJ van Vulpen M van der Heide UA Intrafraction motion of the prostate during external-beam radiation therapy: Analysis of 427 patients with implanted fiducial markers Int J Radiat Oncol Biol Phys 2007, 69:419-425. 17513059
20. Nederveen AJ van der Heide UA Hofman P Welleweerd H Lagendijk JJ Partial boosting of prostate tumours Radiother Oncol 2001, 61:117-126. 10.1016/ S0167-8140(01)00405-4 11690676
21. Trotti A Byhardt R Stetz J Gwede C Corn B Fu K Gunderson L McCormick B Morrisintegral M Rich T Shipley W Curran W Common toxicity criteria: version 2.0. an improved reference for grading the acute effects of cancer treatment: Impact on radiotherapy Int J Radiat Oncol Biol Phys 2000, 47:13-47. 10758303
22. Cox JD Stetz J Pajak TF Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) Int J Radiat Oncol Biol Phys 1995, 31:1341-1346. 7713792
23. Teh BS Dong L McGary JE Mai WY Grant W III Butler EB Rectal wall sparing by dosimetric effect of rectal balloon used during intensity-modulated radiation therapy (IMRT) for prostate cancer Med Dosim 2005, 30:25-30. 15749008
24. Heemsbergen WD Peeters ST Koper PC Hoogeman MS Lebesque JV Acute and late gastrointestinal toxicity after radiotherapy in prostate cancer patients: Consequential late damage Int J Radiat Oncol Biol Phys 2006, 66:3-10. 16814954
25. Koper PC Jansen P van Putten W van Os M Wijnmaalen AJ Lebesque JV Levendag PC Gastro-intestinal and genito-urinary morbidity after 3D conformal radiotherapy of prostate cancer: Observations of a randomized trial Radiother Oncol 2004, 73:1-9. 10.1016/j.radonc.2004.07.020 15465140
26. Peeters ST Hoogeman MS Heemsbergen WD Slot A Tabak H Koper PC Lebesque JV Volume and hormonal effects for acute side effects of rectum and bladder during conformal radiotherapy for prostate cancer Int J Radiat Oncol Biol Phys 2005, 63:1142-1152. 15939547
27. Schultheiss TE Lee WR Hunt MA Hanlon AL Peter RS Hanks GE Late GI and GU complications in the treatment of prostate cancer Int J Radiat Oncol Biol Phys 1997, 37:3-11. 9054871